Key diabetes drug study was flawed, review charges
by admin on 10/07/10 at 2:44 pm
The popular diabetes drug Avandia may be far more dangerous to patients than reported in a study touted by the drug’s manufacturer, according to a strongly worded report posted Friday by the Food and Drug Administration.
